Menu Search
Equities

Kyivmedpreparat AT

KMED:UAX

Kyivmedpreparat AT

Actions
  • Price (UAH)20.00
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 60 minutes, as of Jan 10 2022.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Kyivmedpreparat PAT (Kyivmedpreparat OJSC) is a Ukraine-based company active within the pharmaceutical industry. The Company is principally engaged in the production of anti-bacterial medications. Its products portfolio consists of injections, coated pills, tablets, capsules, gels and ointments, among others. Along with it, the Company produces a variety of veterinary drugs, such as antibacterial, cardiological, gastrointestinal, dermatological and anthelmintics, among others. The Company also has it own lab facilities, including chemical, biological, pharmacological and sanitary-epidemic. Kyivmedpreparat VAT is a part of the Arterium Corporation, engaged in the Ukrainian pharmaceutical industry.

  • Revenue in UAH (TTM)541.16m
  • Net income in UAH34.38m
  • Incorporated1992
  • Employees869.00
  • Location
    Kyivmedpreparat ATvul.Saksahans'koho, 139KIEV 01032UkraineUKR
  • Phone+380 444907519
  • Fax+380 442169645
  • Websitehttps://kievmedpreparat.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.